Login

Driving Ambition: Oxford Metrics features Chris Barnes, CEO of Tracsis Plc, segment by Cavendish 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
IronRidge Resources: African Gold and Lithium Assets
00:10:00
Why Startups Innovate Faster than Internet Giants|Hurst lin,General Partner, DCM
00:10:00
no one could change the rules on you|Yoko Hongyu Li,Partner,Andreessen Horowitz
00:00:00
Pixium Vision - executive interview / Lloyd Diamond CEO, Pixium Vision
00:10:00
Is Long-Term Care Insurance Right for You? Exploring Its Purpose and Benefits | Dr. David Ashby, Co-Founders , Mustard Seed Wealth Management.
00:10:00
Value Investing in a Changing World: Adapting Strategies for Sustainable Success | Dato’ Seri Cheah Cheng Hye, Co-Chairman , Value Partners .
00:10:00
Understanding the Macroeconomic Landscape: Dr. Victor A. Abola
00:10:00
"Building Investment Success: Insights from Robert Gardiner of Grandeur Peak Funds | Robert Gardiner - Co-Founder & CEO, Grandeur Peak Funds"
00:10:00
BW LPG Lists on NYSE: CEO Discusses Returns-Focused Strategy and LPG Market | Kristian Sørensen - CEO of BW LPG
00:00:00
Ceapro using patented technology to disrupt the natural health care products - Gilles Gagnon, President and Chief Executive Officer, Ceapro
00:10:00
Expanding Horizons: The Case for Adding International Stocks to Your Portfolio
00:10:00
2023 WE Learn and Grow Event | Ryan McMonagle, CEO, Custom Truck One Source IncCTOS:NYQ

© 2017 - Neuhu+